Login / Signup
Mutant KRAS inhibitors enter the scene of precision therapeutics for pancreatic cancer.
Gareth Pollin
Gwen L Lomberk
Angela Joy Mathison
Michael T Zimmermann
Raul A Urrutia
Published in:
Journal of gastrointestinal oncology (2024)
Keyphrases
</>
wild type
small molecule